(Q37217845)

19 August 2017

1 reference

title

Examining the evidence: complementary adjunctive therapies for multiple sclerosis (English)

1 reference

19 August 2017

0 references

Mike Namaka

1

1 reference

19 August 2017

Arla Crook

2

1 reference

19 August 2017

Andrea Doupe

3

1 reference

19 August 2017

Kulwinder Kler

4

1 reference

19 August 2017

Marcus Vasconcelos

5

1 reference

19 August 2017

Meghann Klowak

6

1 reference

19 August 2017

Yuewen Gong

7

1 reference

19 August 2017

Alicja Wojewnik-Smith

8

1 reference

19 August 2017

Maria Melanson

9

1 reference

19 August 2017

15 July 2008

1 reference

19 August 2017

Neurological Research

1 reference

19 August 2017

30

1 reference

19 August 2017

7

1 reference

19 August 2017

710-719

1 reference

How frequently do patients with multiple sclerosis use complementary and alternative medicine?

19 August 2017

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Self reported stressful life events and exacerbations in multiple sclerosis: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Dietary management in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

New clues about vitamin D functions in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Bee venom, immunostimulant or immunosuppressor? Insight into the effect on matrix metalloproteinases and interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Holotranscobalamin--a first choice assay for diagnosing early vitamin B deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Diet and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Ultrasonographic evaluation of fetal facial anatomy (I): ultrasonographic features of normal fetal face in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Cytokine profile in patients with multiple sclerosis following vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Immunopathogenesis of multiple sclerosis: the role of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Psychological stress and the subsequent appearance of new brain MRI lesions in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Dorsal root ganglia may be reservoirs of viral infection in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Randomized controlled trial of yoga and exercise in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Cytokines in multiple sclerosis: methodological aspects and pathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Nutrition and diet in the clinical management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Multiple sclerosis and vitamin B12 metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Organic solvents and the risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Treadmill training for individuals with multiple sclerosis: a pilot randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Antioxidants and polyunsaturated fatty acids in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

A randomized crossover study of bee sting therapy for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Lipoic acid in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Bee venom melittin blocks neutrophil O2 ? production

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

Factors influencing sib risks for Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X325038

21 January 2018

Identifiers

DOI

10.1179/174313208X325038

1 reference

release_tkhwejud4batbe7zdnl2hyp5xy

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tkhwejud4batbe7zdnl2hyp5xy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference